{
  "docId": "019de075-7c2e-7510-9012-23bac78506e5",
  "docSlug": "6afb08ad9ecba2144545352067526476",
  "documentTitle": "Bluejay | Investor Presentation Deck | 20 slides",
  "authorId": "bluejay",
  "authorName": "Bluejay Diagnostics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 20,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Gantt-style chart to show the progress of three different diagnostic tests across four development phases.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-7c2e-7510-9012-23bac78506e5/12",
  "deckHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5",
  "deckJsonHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5.json",
  "deckAnchorHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.48,
        "w": 0.924,
        "x": 0.038,
        "y": 0.26
      },
      "kind": "chart",
      "text": "Pipeline progress chart",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25a37b0c-6510-4d64-9451-09c68201c034",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.48,
        "x": 0.135,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "The Symphony™ System and Symphony™ Cartridge have not been cleared or approved by the U.S. FDA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf75a49f-f54c-42aa-8d6b-aa482a68a7b5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.924,
        "x": 0.038,
        "y": 0.145
      },
      "kind": "paragraph",
      "text": "Well-validated critical care biomarkers. Tests with potential clinical and cost-saving benefits gained from faster turnaround times",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6aa41482-e1fc-4572-b54b-d56309c8ab6c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.38,
        "x": 0.31,
        "y": 0.83
      },
      "kind": "title",
      "text": "New Tests Will Follow the IL-6 Development Pathway",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09e14f24-95ad-4a8b-ad01-26f35d800be3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.345,
        "x": 0.038,
        "y": 0.085
      },
      "kind": "title",
      "text": "Symphony™ Product Pipeline",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e40b09e-452d-4e93-ba00-b6b8fba5e869",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "e8064e59-e272-4b88-b064-73306fa4ed49",
      "evidence": "Visual timeline of product development stages",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 20,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c2e62651-f3f1-4333-88f5-3a258ba00fce",
      "evidence": "The deck implicitly discusses the cost of inaction by emphasizing the life-threatening nature of sepsis and the benefits of rapid diagnosis.",
      "position": 0,
      "objective": "Highlight the cost of not acting quickly in sepsis diagnosis and treatment.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}